Clinical trial on trial on eraippu erumal with yoga therapy

Phase 2

Completed

Conditions: Respiratory conditions due to unspecified external agent,

Registration Number: CTRI/2019/06/019754

Lead Sponsor: S MUTHU VIGNESH

Brief Summary: Bronchial asthma is a verycommon disease in the society due to increasing exposure to air pollution andwestern life style.It is common in both sex but more prevalent among males,while during adolescence and adulthood,it affects girls and women more. Bronchial Asthma (from the Greek-Panting) is a chronicinflammatory disease which produces bronchial hypersensitivity characterised byreversible airway obstruction, mucosal oedema, constriction of the bronchialmusculature and excessive secretion of viscid mucus,causing mucous plugs.

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 40

Inclusion Criteria

Patient with the symptoms of Nasal congestion Rhinorrhea Tightness of chest Recurrent attacks of dyspnoea Cough with expectoration Wheezing added sound (Rhonchi) H/O allergy, sneezing.
Patients who are willing to take radiological investigation and provide blood for lab investigation.

Exclusion Criteria

Patient with Age group less than 15 and above 65 years Systemic Hypertension Cardiac disease Renal disease Tuberculosis Chronic Bronchitis Status Asthmaticus Auto immune disease.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Before and after treatment measurements of HR/PR/RR/BP will give the efficacy data	Group I - Intermittent siddhar yogam therapy within 48 days \| Ist sitting 50 percentage of symptoms will reduce \| IInd sittind 80 percentage of symptoms will reduce \| Group II after giving internal medicine for 48 days 40 percentage of symptoms will reduce \| After giving both internal and external yoga therapy for 48 days 80 percentage of symptoms will reduce
Hopefully helps to know about the comparative therapeutic efficacy data	Group I - Intermittent siddhar yogam therapy within 48 days \| Ist sitting 50 percentage of symptoms will reduce \| IInd sittind 80 percentage of symptoms will reduce \| Group II after giving internal medicine for 48 days 40 percentage of symptoms will reduce \| After giving both internal and external yoga therapy for 48 days 80 percentage of symptoms will reduce

Secondary Outcome Measures

Name	Time	Method
Before and after treatment measurements of HR/PR/RR/BP will give the efficacy data	Hopefully helps to know about the comparative therapeutic efficacy data

Trial Locations

Locations (1): GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI TIRUNELVELI
🇮🇳
Tirunelveli, TAMIL NADU, India
GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI TIRUNELVELI
🇮🇳Tirunelveli, TAMIL NADU, India
S MUTHU VIGNESH
Principal investigator
9566757400
am030294@gmail.com